Clinical trial Recruiting at 1 site Interventional Ages 5 to 13

Ultrasound-guided glossopharyngeal and maxillary nerve blocks for pain control after adenotonsillectomy

Official title: Ultrasound Guided Glossopharyngeal and Maxillary Nerve Blocks for Perioperative Pain Control in Adenotonsillectomy in Pediatrics: A Randomized Controlled Trial.

Run by Cairo University · NCT07379866 · Data updated 2026-11-12

Doctors will test whether adding ultrasound-guided glossopharyngeal and maxillary nerve blocks to usual pain control reduces pain after adenotonsillectomy in children aged 5–13.

More Regional Anesthesia trials

Quick facts

Study typeInterventional
Ages5 Years to 13 Years
SexAll
Enrollment40 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo, Governorate)
StatusRecruiting
StartedJanuary 2026
Main results expectedMay 2026
Study endsJune 2026
Registry record updatedFebruary 2, 2026
Trial IDNCT07379866 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5–13 years with ASA physical status I–II who are scheduled for adenotonsillectomy and have no contraindication to local anesthetics or nerve block procedures.

Probably not a fit

Children who are ASA class III–IV, morbidly obese, have infection at the injection site, recent upper respiratory infection, allergy to local anesthetics, developmental delays, recent regular analgesic use, or whose parents refuse participation are not eligible and would not receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study enrolls pediatric patients aged 5 to 13 undergoing adenotonsillectomy at Cairo University Hospitals. After standard premedication and induction of general anesthesia, participants are randomized to receive combined bilateral ultrasound-guided glossopharyngeal and maxillary nerve blocks plus standard multimodal analgesia or to receive standard multimodal analgesia alone (placebo block group). Standard intraoperative monitoring, IV analgesics including paracetamol, and anesthetic techniques are used for all patients. Outcomes focus on postoperative pain control and analgesic requirements following the operation.

Why it matters

Potential benefit: If successful, the nerve-block approach could lower postoperative pain and reduce the need for systemic opioids in children after adenotonsillectomy.

How similar studies have gone: Previous studies of regional nerve blocks for tonsillectomy have reported reduced postoperative pain and opioid use, though combined ultrasound-guided glossopharyngeal plus maxillary blocks are less extensively studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients aged 5 to 13 years
* American Society of Anesthesiologists (ASA) physical status I-II scheduled for adenotonsillectomy.

Exclusion Criteria:

* Parents Refusal
* Cognitive impairment or developmental delays.
* Infection at injection site.
* Recent upper respiratory tract infection.
* Post-tonsillectomy bleeding, allergy to local anesthetics.
* American Society of Anesthesiologists (ASA) class III and IV.
* Morbid obesity.
* Those receiving regular analgesia within the last week before surgery.

Where it's running

  • Cairo University Hospitals
    Cairo, Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.